The DJS Law Group reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake ” or “the Company”) (NASDAQ: MLTX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MLTX during the […]

The DJS Law Group reminds investors of a class action lawsuit against WPP plc (“WPP” or “the Company”) (NYSE: WPP ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of WPP during the class

The DJS Law Group reminds investors of a class action lawsuit against KBR, Inc. (” KBR” or “the Company”) (NYSE: KBR ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of KBR during the

The DJS Law Group reminds investors that it is investigating claims against Fluor Corporation (“Fluor” or “the Company”) (NYSE: FLR) for violations of securities laws. The investigation centers on whether the Company made false and/or misleading statements or omitted information critical to investors. On August 1, 2025, Fluor announced its second-quarter financial results and reduced

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstCytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's

The DJS Law Group reminds investors of a class action lawsuit against Lantheus Holdings, Inc. (“Lantheus ” or “the Company”) (NASDAQ: LNTH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of LNTH during

Austin, TX, USA, Oct. 23, 2025 (GLOBE NEWSWIRE) — Custom Market Insights has published a new research report titled “Radiopharmaceutical CDMO Market Size, Trends and Insights By Application (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals), By Radioisotope Type (Technetium-99m, Fluorine-18, Lutetium-177, Gallium-68, Actinium-225, Others), By Source of Manufacturing (Nuclear Reactors, Cyclotrons), By Therapeutic Area (Oncology, Neurological Disorders, Cardiovascular

(NASDAQ:IDCC), WILMINGTON, Del., Oct. 23, 2025 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced it has renewed a multi-year, worldwide, non-exclusive, royalty bearing license with Seiko Solutions Inc. The license covers Seiko Solution Inc.'s cellular products under InterDigital's standard essential patents related to 3G,

[Latest] Global Radiopharmaceutical CDMO Market Size/Share Worth USD 7.2 Billion by 2034 at a 9.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Radiopharmaceutical CDMO Market size

InterDigital renews license agreement with Seiko Solutions Inc. GlobeNewswire October 23, 2025 WILMINGTON, Del., Oct. 23, 2025 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced it has renewed a multi-year, worldwide, non-exclusive, royalty bearing license with Seiko Solutions Inc. The license covers Seiko Solution